UnitedHealth shares fell 10.21% and Humana 12.98% on Wednesday 18 November, a second day of heavy losses for US health insurers after Medicare's regulator proposed a tougher way to claw back overpayments. The CRUSH proposal would let auditors apply the error rate found in a small sample of Medicare Advantage patients to a whole contract, starting with payment year 2018, and CMS puts the haul at about $9bn a year.
The audit rule in numbers
- $9bn average yearly recovery CMS expects from extrapolated Medicare Advantage audits
- 15.1% UnitedHealth's two-day fall, from $412.02 on Monday to $349.91
- 12.98% Humana's drop on Wednesday, the steepest among the big insurers
Why UnitedHealth and Humana shares fell two days running
The selling hit every big company running Medicare Advantage plans, the private alternative to traditional Medicare in which insurers cover older Americans and are paid by the government per member.
| Insurer | Tuesday 17 November | Wednesday 18 November | Wednesday close |
|---|---|---|---|
| Humana | -3.88% | -12.98% | $385.78 |
| UnitedHealth | -5.42% | -10.21% | $349.91 |
| Elevance Health | -2.77% | -7.63% | $400.84 |
| Centene | -2.97% | -7.03% | $67.45 |
Humana lost 16.4% over the two sessions. The wider market held up better: the S&P 500 slipped 0.2% for a fifth straight loss, its longest losing run since June, according to the Associated Press, a streak that took in Monday's slide in chip stocks. The Dow Jones Industrial Average fell 561.25 points, or 1.1%, to 50,198.17.

What the CMS CRUSH proposal would change for Medicare Advantage
On Monday 16 November the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule called Comprehensive Regulations to Uncover Suspicious Healthcare, or CRUSH. Most of it targets fraud by providers, equipment suppliers and brokers. The part that moved the shares concerns Risk Adjustment Data Validation (RADV) audits.
Medicare Advantage insurers are paid more for sicker members: each diagnosis a plan records can raise a member's "risk score", and with it the payment. A RADV audit checks a sample of medical records to see whether those diagnoses are backed up.
According to the CMS fact sheet, the agency would begin extrapolating audit findings with payment year 2018 audits and would not apply a fee-for-service adjuster. That adjuster was meant to keep plans' payments in line with traditional Medicare, a principle known as actuarial equivalence, Healthcare Dive has explained.
"Every taxpayer dollar lost to fraud is a dollar that cannot support the care these programs were created to provide," CMS Administrator Dr Mehmet Oz said in the agency's press release.
How extrapolated audits could hit insurers' earnings
Without extrapolation, an insurer repays only the unsupported payments found in the sampled records. With it, the error rate from the sample is applied to every member of the contract. Put simply, if one sampled dollar in ten was unsupported, CMS could seek back roughly a tenth of the whole contract's payments.
CMS estimates the approach would recover an average of about $9bn of overpayments per payment year. Its earlier version of the rule was expected to bring in about $4.7bn over ten years, according to Healthcare Dive.
Money handed back comes straight off insurers' revenue, and reaching back to 2018 could reopen payments booked years ago. Mizuho analyst Ann Hynes named UnitedHealth and Humana as the most exposed, followed by CVS Health, Elevance Health, Centene and Molina Healthcare, FX Leaders reported. UnitedHealth runs the country's largest Medicare Advantage business, and Healthcare Dive describes Humana as the second-largest payer in the programme.
Why a court struck down the similar 2023 audit rule
CMS has tried this before. A RADV rule finalised in February 2023 also dropped the adjuster and allowed extrapolation back to 2018. Humana sued, and on Thursday 25 September 2025 Judge Reed O'Connor of the US District Court for the Northern District of Texas vacated the rule.
His objection was about process rather than the idea itself. He found that CMS had given no meaningful notice of its reasoning for dropping the adjuster, and wrote that "Plaintiffs, and others, will potentially bear enormous unforeseen costs," Healthcare Dive reported. Healthcare Dive and the law firm Groom Law Group both noted that CMS could start again with fresh notice and comment. CRUSH is that new attempt, which is why the market is taking it seriously.
When the CRUSH comment period ends and what happens next
CRUSH is a proposal, not a final rule. CMS says comments are due by Tuesday 19 January 2027, after which it can change, finalise or drop it.
The pressure is political too. Senator Elizabeth Warren has called for breaking up vertically integrated health groups, naming UnitedHealth, CVS and Cigna, FX Leaders reported. That call carries more weight after Democrats won both chambers of Congress earlier this month. Our markets coverage follows the insurers as the comment period runs.
Why did UnitedHealth and Humana stock drop?
UnitedHealth fell 10.21% and Humana 12.98% on Wednesday 18 November after CMS proposed extrapolating Medicare Advantage audit errors across whole contracts from payment year 2018, which it says would recover about $9bn a year.
What is the CMS CRUSH rule?
CRUSH (CMS-6098-P) is an anti-fraud proposal CMS issued on Monday 16 November covering Medicare, Medicaid and the ACA Marketplace, which it says would save nearly $90bn from 2027 to 2036.
Is the Medicare Advantage audit rule final?
No. CRUSH is a proposal, with comments due by 19 January 2027. A federal court vacated a similar rule in September 2025.
Sources
- Centers for Medicare & Medicaid Services: Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) Proposed Rule (CMS-6098-P) fact sheet
- Centers for Medicare & Medicaid Services: CMS CRUSH proposed rule aims to reap nearly $90 billion for taxpayers in savings by targeting fraud
- Healthcare Dive: CMS proposes sweeping reforms to curb healthcare fraud
- StockAnalysis: UnitedHealth Group (UNH) stock price history
- StockAnalysis: Humana (HUM) stock price history
- StockAnalysis: Elevance Health (ELV) stock price history
- StockAnalysis: Centene (CNC) stock price history
- Associated Press via Baltimore Sun: A fifth straight drop for the S&P 500 drags Wall Street to its longest losing streak since June
- FX Leaders: UnitedHealth Faces $9 Billion Industry Clawback Under New CMS Rules
- Healthcare Dive: Judge vacates Medicare Advantage audit rule in win for industry
- Groom Law Group: Court rules that CMS cannot extrapolate Medicare Advantage risk adjustment audit results








